Molecular diagnostics involves measuring DNA, RNA, proteins, or metabolites to detect genotypes, mutations, or biochemical changes associated with health or disease. PCR and cytogenetic analysis are common techniques used for infectious diseases, oncology, hereditary conditions, and prenatal testing. Personalized medicine is the future of molecular diagnostics.
Molecular diagnostics can be broadly defined as the measurement of deoxyribonucleic acid (DNA), ribonucleic acid (RNA), proteins or other metabolites to detect certain genotypes, mutations or biochemical changes that may be associated with certain states of health or disease. The emergence of molecular diagnostics is due to advances in biology that have led to the understanding of the mechanisms of normal and pathological processes at the molecular level. Prior to this understanding, many disease states were diagnosed from morphological observations.
The first widely used molecular tests were for infectious diseases, such as hepatitis B and C or human papillomavirus (HPV), and this continues to be the largest market in molecular diagnostics. Some other fields, such as molecular testing for oncology, hereditary conditions, cardiovascular disease, neurological disorders, and forensic testing, are rapidly growing areas of interest. Additionally, molecular diagnostics can be used to monitor a patient’s response to a particular drug treatment.
Many different biological techniques fall under the umbrella of “molecular diagnostics”. One of the most common techniques is polymerase chain reaction (PCR), a method of producing large quantities of specifically defined DNA or RNA fragments that can be used for multiple purposes, including pathogen identification and disease detection. aberrant gene expression associated with certain diseases. PCR fragments can also be sequenced to detect genetic mutations linked to certain disease states, such as the detection of mutations in the BRCA1 and BRCA2 genes that are often associated with an increased risk of hereditary breast cancer and ovarian cancer.
Another widely used technique is cytogenetic analysis, which involves examining chromosomes to diagnose or identify certain diseases or genetic abnormalities. This technique is often used in oncology. Using known genetic markers, it is possible to detect the presence of cancer cells within a biological sample. Additionally, cytogenetic analysis of tumor samples can often provide information on tumor aggressiveness or the likelihood of tumor recurrence. Cytogenetic analysis is also useful in prenatal genetic testing to screen for a particular birth defect or chromosomal abnormality in the fetus.
The most anticipated development from molecular diagnostics is the concept of personalized medicine, which refers to the ability to tailor a treatment plan specifically to an individual based on their genetic makeup. This would identify patients who may respond well to a particular drug and help avoid adverse drug effects. It would also determine a person’s risk for particular diseases before developing the disease. This concept is already being used to some extent to identify people who are prone to certain genetic diseases, such as cystic fibrosis, some cancers and Alzheimer’s disease.
Protect your devices with Threat Protection by NordVPN
